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Vps28γ2-Adaptin is a clathrin adaptor-related protein with unclear physiological function. Previous studies
indicated that γ2-adaptin might act within the multivesicular body (MVB) protein-sorting pathway that is
central to receptor down-regulation, lysosome biogenesis, and budding of enveloped viruses. Here, we have
analyzed the effects of excess and deﬁcit γ2-adaptin on exogenous and endogenous MVB cargoes and on
the MVB machinery itself. Foreign cargoes, like retroviral Gags, are entrapped by overexpressed γ2-adaptin
in detergent-insoluble polymers and blocked in budding. When viral budding involves MVB/endosomal
structures, excess γ2-adaptin acts by accelerating lysosomal Gag destruction. Consistently, depletion of γ2-
adaptin avoids Gag routing to the lysosome and increases viral production. Functional studies with natural
MVB cargoes support a role of γ2-adaptin in MVB-to-lysosome transition. Furthermore, we show that
different members of the endosomal sorting complex required for transport (ESCRT) that drive sorting from
endosomes to lysosomes are sequestered upon γ2-adaptin overexpression. If sequestered irreversibly, they
are targeted to enhanced lysosomal degradation. The participation of γ2-adaptin in MVB sorting is further
suggested by our ﬁnding that it speciﬁcally interacts with the ESCRT subunits Vps28 and CHMP2A. These
observations identify γ2-adaptin as a critical factor in MVB trafﬁcking, which likely is involved in endosome-
to-lysosome maturation.+49 6131 179021.
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The endosomal system of eukaryotic cells receives and sorts cargo
proteins from both endocytic and biosynthetic pathways. Endosomal
sorting involves the biogenesis of multivesicular bodies (MVBs)
that arise from internal budding of endosomal membranes. In this
pathway, selected transmembrane cargo destined for either degra-
dation, lysosomal functions, or exosomal release are sequestered into
inwardly budding vesicles (intraluminal vesicles, ILV) that form by
the invagination and detachment of the limiting membrane of the
endosomes. The MVBs then fuse with the lysosome to deliver the
luminal vesicles and their contents to this organelle. MVBs can also
fuse with the plasma membrane, in an exocytic manner, to release
internal vesicles into the extracellular milieu [1–4].
Both the sorting of cargo into MVBs and the biogenesis of these
compartments depend on the endosomal sorting complex required
for transport (ESCRT) system. In mammals, this system consists of the
ESCRT-0, -I, -II, and -III complexes together with Vps4, Alix and other
associated proteins that seem to function in a sequential manner.
ESCRT-0, -I, and -II are soluble, contain ubiquitin-binding domains,
and are primarily involved in sorting of ubiquitinated cargo and in therecruitment and activation of ESCRT-III. Activated ESCRT-III appears to
be the core of the machinery and is composed of various CHMPs
(charged multivesicular body proteins), responsible for the budding
and membrane ﬁssion events during ILV formation. Finally, speciﬁc
ESCRT-III subunits recruit the ATPase Vps4 that dissembles and
releases the complexes upon ATP hydrolysis for recycling [1,2,5,6].
The ESCRT complexes and associated proteins have been found to
also play roles in enveloped virus budding, a process analogous to
MVB vesicle formation with the same topological requirement [6–8].
A number of retroviruses, including human immunodeﬁciency virus
(HIV), equine infectious anemia virus (EIAV), and murine leukemia
virus (MLV), as well as DNA viruses, like the hepatitis B virus (HBV)
and herpes viruses, require the core ESCRT machinery for budding
[9–14]. Viruses access the MVB pathway through so-called late
assembly domains (late domains) of their structural proteins which
contain three alternative sequences, P(S/T)AP, LYPXL, and PPXY. P(S/T)
AP late domains function as recruitment sites for Tsg101, the ubiquitin-
binding subunit of ESCRT-I. The LYPXL motifs bind to Alix, an ESCRT-I
and -III interaction partner, and the PPXY late domains bind HECT-
domain ubiquitin ligases, likeNedd4 [9,10,15,16]. Deletion of these sites
causes the failure ofmembrane abscission and the accumulation of viral
buds at the plasma membrane or MVBs [9,10,17].
The investigation of viral budding is a powerful instrument in the
understanding of MVB biogenesis and resulted in the discovery of
hitherto unknown players involved in this pathway. For instance, HBV
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III and Vps4, but also depends on the action of Nedd4 and γ2-adaptin
[12,13,16]. Unlike retroviruses, HBV nucleocapsid budding from
infected cells strictly depends on the viral envelope that is tethered
to the capsid via γ2-adaptin [16,18,19]. Accordingly, γ2-adaptin was
assumed to play a speciﬁc role in HBV morphogenesis. However,
consecutive analyses indicated that γ2-adaptin might operate within
the MVB sorting system [12,20].
γ2-Adaptin is highly similar to γ1-adaptin, one large subunit of the
heterotetrameric trans-Golgi network/endosome adaptor protein
complex AP-1, but appears to function independently [21–23]. This
is evidenced by embryonic lethality of γ1-adaptin knockout mice and
by the inability of γ1-adaptin to functionally substitute γ2-adaptin
during HBV egress [16,24]. Unlike classic adaptin proteins, γ2-adaptin
does not depend on the GTPase Arf1 for membrane recruitment and
possesses ubiquitin-interacting ability [16,21,23]. Indications for a
linkage of γ2-adaptin to endosomal/MVB sorting pathways are based
on the ﬁndings that (i) it functionally interacts with Nedd4 [11], its
depletion impairs the degradation of internalized epidermal growth
factor and induces an endosomal enlargement, and (iii) its over-
expression perturbs MVB morphology and inhibits budding of HBV
and MLV, both PPXY late domain-containing viruses [12,16,20].
As a step toward understanding the role of γ2-adaptin in
endosomal/MVB trafﬁcking, we examined the fate of exogenous
and endogenous MVB cargoes and of key MVB molecules under
conditions of deﬁcit and excess γ2-adaptin. We show that altering γ2-
adaptin levels interfere with proper MVB function and MVB-to-
lysosome maturation. In addition, we provide evidence for a link
between γ2-adaptin and the MVB apparatus by demonstrating that
this adaptor associates with ESCRT-I and -III subunits in vivo.
2. Material and methods
2.1. Expression constructs
The γ2-adaptin expression vector contains the human γ2-adaptin-
speciﬁc cDNA with an N-terminal hemagglutinin (HA) tag and was
provided by K. Nakayama (Tsukuba University, Japan) [21]. The
constructions of the γ2-adaptin deletion mutants HA.γ2Δ528-785,
HA.γ2Δ193-785, and HA.γ2Δ2-522 had been described [16,20]. The
expression vector of EIAV Gag full-length precursor protein in which
the viral polymerase was replaced by EGFP gene was a gift from
S. Gould (Johns Hopkins University School of Medicine, Baltimore,
USA) [25]. The plasmid pGag-EGFP contains the Gag gene of HIV type
1 fused to enhanced green ﬂuorescent protein (EGFP) [26] and was
obtained through the NIH AIDS Research Reference and Reagent
Program (cat #11468). Full-length cDNA clones encoding human
Vps28 (IRATp970D0777D6), EAP30 (IRATp970E025D), CHMP2A
(IRATp970H0473D), CHMP3 (IRAUp969E0324D), CHMP4B
(IRATp970H0653D), or CHMP4C (IRAUp969F0569D) were obtained
from imaGenes (Germany). The corresponding coding regions were
PCR-ampliﬁed and cloned into p3xFLAG-CMV-10 or p3xFLAG-CMV-
14 (Sigma-Aldrich). Cloning details are available on request. Plasmid
pCHMP3.YFP encodes a dominant negative (dn) mutant of CHMP3
with a C-terminal insertion of yellow ﬂuorescent protein (YFP)
(provided by E. Gottwein, University of Heidelberg, Germany). The
Vps4A-speciﬁc expression vectors, gifts from W. Sundquist (Univer-
sity of Utah, USA), encode the wild-type (wt) Vps4A protein or its
dn E228Q point mutant fused in frame to the C-terminus of EGFP
[9]. The plasmid pLamp1-RFP carrying Lamp1 with a C-terminal fused
red ﬂuorescent protein (RFP) was provided by W. Mothes (Yale
University Medical School, USA) via Addgene as “Addgene plasmid
1817”. As amarker for the plasmamembrane, cyanﬂuorescent protein
(CFP)-tagged zyxin encoded by plasmid pECFP-zyxin was used (a
gift from M. Husmann, University of Mainz, Germany, provided by
P. Lapalainen [27]).2.2. siRNAs
For RNA interference against γ2-adaptin, we used the oligonucle-
otide #690 as described previously [16]. To inhibit the expression
of Alix, siRNA duplexes targeting the nucleotide positions 2600–2618
of Alix (GCAGTAATATGTCTGCTCA) were used (Sigma-Aldrich). To
silence the expression of Tsg101, siRNAs directed against nucleotide
positions 417–435 (CCAGTCTTCTCTCGTCCTA) were employed. For
depletion of clathrin, siRNA duplexes against nucleotide positions
3310–3328 of the heavy chain (AACCTGCGGTCTGGAGTCAAC) were
used (Sigma-Aldrich). As a control, a nonsense siRNA with no known
homology to mammalian genes was applied (Qiagen).
2.3. Antibodies and reagents
Commercially available antibodies were as follows: mouse anti-β-
actin antibodies (Sigma-Aldrich), mouse anti-γ1-adaptin antibodies
(Sigma-Aldrich), mouse anti-clathrin antibodies (BD Biosciences),
mouse anti-FLAG antibodies (Sigma-Aldrich), mouse anti-GFP anti-
bodies (BD Biosciences, Clontech), mouse antibodies against the HA-
epitope tag (BabCO),mouse antibodies against tubulin (Sigma-Aldrich),
and mouse antibodies recognizing ubiquitinated proteins (FK2; Bio-
mol). For detection of untagged γ2-adaptin, a rabbit antiserum gen-
erated against the C-terminal 19 amino acidswas used [18]. Peroxidase-
labeled, secondary antibodies were obtained from Dianova, and
ﬂuorophor-labeled antibodies were from Molecular Probes. The
proteasome inhibitor MG-132 was obtained from Sigma-Aldrich and
used in a 10 μMworking concentration for 3 h.
2.4. Cell culture and transfection
The human hepatocellular carcinoma cell line HuH-7 was used
throughout. Transfections with plasmid DNAs were performed with
Lipofectamine™ Plus (Invitrogen). The amounts of plasmid DNA
used in (co)transfection experiments are indicated in the ﬁgure
legends. For transfection of cells with siRNAs plus plasmid DNA,
the Lipofectamine™ RNAiMAX transfection reagent (Invitrogen) was
used. Brieﬂy, 5×105 cells per well of a 6-well plate were transfected
with 100 pmol siRNA according to the protocol of the supplier.
After 48 to 72 h, cells were retransfected with plasmid DNA using
Lipofectamine™ Plus, and cells were harvested after additional 24 h.
2.5. Inhibition of lysosomal degradation
Two days after transfection, cell culture medium was replaced
with DMEM containing 100 μg/ml cycloheximide (Sigma-Aldrich)
and cells were incubated for 1 h to arrest protein synthesis. For
lysosomal inhibition, the cells were next incubated with DMEM/
100 μg/ml cycloheximide with or without 30 μM chloroquine (Sigma-
Aldrich) and 20 mMNH4Cl for 1 h. Cells werewashed and reincubated
for 3 h in the presence or absence of 30 μM chloroquine+20 mM
NH4Cl.
2.6. Cell lysis and virus-like particle (VLP) analysis
To probe for protein expression and protein solubility, cells
were lysed with either the non-denaturing detergent Triton X-100
or the denaturing reagent sodium dodecylsulfate (SDS). Triton X-100
lysates were prepared by incubating the cells with Tris-buffered
saline (TBS, 50 mM Tris–HCl, pH 7.5, 150 mM NaCl) containing 0.5%
Triton X-100 for 20 min on ice. Thereafter, lysates were centrifuged
for 5 min at 15,000×g and 4 °C. For cell lysis with SDS, the cells were
scraped from the plates using 1× Laemmli buffer, and cell suspensions
were boiled for 10 min prior to centrifugation. To analyze the
assembly and release of VLPs from transfected cells, clariﬁed culture
medium was ﬁltered on 0.45-μm membranes and concentrated by
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and 4 °C). Pellets were suspended in TBS and mixed with 1× Laemmli
buffer.
2.7. Coimmunoprecipitation assay
To probe for complex formation, cotransfected cells were lysed
with a 2% solution of the non-denaturating detergent CHAPS {3-[(3-
cholamidopropyl)-dimethylammonio]-1-propanesulfonate}-HBS
(50 mM Hepes–KCl, pH 7.5, 200 mM NaCl), supplemented with 1×
protease inhibitor mixture (Serva) for 20 min on ice. After centrifu-
gation, lysates were immediately subjected to immunoprecipitation
as described previously [20]. Total protein extracts corresponding to
10% of the lysates were included on the gel as controls.
2.8. Fluorescence microscopy
Immunoﬂuorescence analyses were performed as described
previously [20]. Brieﬂy, two days after transfection, cells were ﬁxed
and permeabilized with ice-cold methanol containing 2 mM EGTA.
Cells were blocked in PBS containing 2% animal serum, incubatedwith
the indicated primary antibodies for 1 h at 37 °C, rinsed with PBS, and
then incubated with AlexaFluor-tagged secondary antibodies for 1 h
at 37 °C. DNA was stained with Hoechst 33342 (Sigma-Aldrich). Z-
stack images were acquired separately for each channel using a Zeiss
Axiovert 200 M microscope equipped with a Plan-Apochromat 100×
(1.4 NA) and a Zeiss Axiocam digital camera. Axiovision software
4.6 was used for merging pictures. Z-stack images were optically
deconvoluted using the software supplied by Zeiss. Tiffs were as-
sembled into ﬁgures using Photoshop CS2 (Adobe). For quantitative
image analyses, images of the immunoﬂuorescence data were col-
lected at identical settings. Digital photographs were quantitated
using ImageJ software by measuring the integrated ﬂuorescence
density of randomly selected cells (40 cells per coverslip). For total
internal reﬂection ﬂuorescencemicroscopy (TIRFM), cells were grown
on glass bottom dishes (MatTeK Corp.). Two days after transfection,
cellswere incubated undermicroscopic observation at 37 °C in a stage-
top CO2 incubator (Incubator S TIRF S1, Zeiss). TIRF images were
obtained with the same microscopic setup equipped with a multiline
argon laser.
2.9. Epidermal growth factor (EGF) uptake and degradation assay
Transfected cells were grown on coverslips and starved in serum-
free OPTIMEMmedium (Gibo-BRL) for 1 h. Cells were then stimulated
with Alexa 488-conjugated EGF (Molecular Probes) (0.02 μg/ml in
OPTIMEM) for 20 min at 37 °C. Following washing, the labeled EGF
was chased by incubating the cells in serum-free medium for 2 h at
37 °C. After the pulse or pulse/chase, cells were ﬁxed in methanol and
processed for ﬂuorescence microscopy.
2.10. Transferrin uptake
Transfected cells were starved for 1 h and incubated with 35 μg/ml
human transferrin labeled with AlexaFluor-546 for 50 min. The
remaining transferrin on the cell surface was removed by treatment
with an acid-wash solution (260 mM citric acid and 125 mM
Na2HPO4) for 1 min. Labeled cells were washed twice with cold PBS,
ﬁxed in methanol and processed for ﬂuorescence microscopy.
3. Results
3.1. Overexpressed γ2-adaptin is a potent inhibitor of retroviral budding
Previously, we showed that overexpressed γ2-adaptin inhibits the
release of HBV viral particles and MLV VLPs [12]. The HBV capsid andthe MLV Gag both contain a PPxY late domain and functionally
interact with the Nedd4 ubiquitin ligase [15,16]. Nedd4 in turn has
been shown to be a binding partner of γ2-adaptin [20]. Hence, the
effect of overexpressed γ2-adaptin on viral release might be a con-
sequence of binding competition in such that excess γ2-adaptin
interacts with Nedd4, thereby reducing the pool of Nedd4 available
for productive interactions with HBV and MLV. Alternatively,
regarding the initial biological characterization of γ2-adaptin, up-
regulated γ2-adaptin potentially acts as a principal inhibitor of the
MVBmachinery and consequently of viral particle production [12,20].
To test these hypotheses, we analyzed the fate of retroviral Gag
proteins that do not harbor a PPxY late domain motif, but require the
MVB machinery for budding. As reporters, we chose HIV and EIAV
Gags whose budding is known to depend on PS/TAP- or YPDL-type
late domains that mediate interactions with Tsg101 or Alix,
respectively [9,10]. For transient expression in HuH-7 liver carcinoma
cells, we used the expression vectors of HIV and EIAV Gag full-length
precursor proteins in which the viral polymerases were replaced by
EGFP [25,26]. First, we assessed whether the HuH-7 cell line confers
the release of EIAV and HIV Gags in an MVB-dependent manner.
Cells were treated with speciﬁc siRNAs to reduce endogenous levels
of Alix or Tsg101 prior to transfection with the EIAV.Gag or HIV.Gag
constructs, respectively. Cell lysates were prepared with the non-
denaturing detergent Triton X-100 and analyzed for the depletion
efﬁcacy of Alix and Tsg101 by immunoblotting. The expression of the
Gags was probed by GFP-speciﬁc Western blotting. As shown in
Fig. 1A, both siRNAs effectively reduced the expression of their targets
as compared to control siRNA-treated cells. The intracellular levels of
EIAV.Gag andHIV.Gagwere unaffected, irrespective of whether Alix or
Tsg101, respectively, were depleted or not. When culturemedia of the
cells were analyzed for VLP release, the loss of Alix inhibited EIAV.Gag
release, while the knockdown of Tsg101 blocked HIV.Gag export
(Fig. 1A). The potent and speciﬁc inhibition of viral Gag budding
conﬁrmed the applicability of the selected HuH-7 cell culture system.
We next investigated the synthesis and release of EIAV.Gag and
HIV.Gag under conditions of γ2-adaptin overexpression. The con-
structs were transfected either alone or together with an HA-tagged
version of γ2-adaptin in HuH-7 cells. HA- and GFP-speciﬁc Western
blotting of cell lysates prepared with Triton X-100 showed efﬁcient
synthesis of γ2-adaptin and the two Gags (Fig. 1B). Intriguingly,
the intracellular levels of both Gags were signiﬁcantly lower when
ectopically expressed γ2-adaptin was present. Consistent with the
intracellular down-regulation, the extracellular release of EIAV
and HIV VLPs was almost completely suppressed in γ2-adaptin-
overexpressing cells (Fig. 1B). These results conﬁrm our previous data
obtained with MLV and HBV [12]. Together, they implicate that
overexpressed γ2-adaptin behaves as a general inhibitor of MVB-
dependent virus budding and suppresses the release of virus-like/
viral particles, independently of their particular late domain and,
consequently, their speciﬁc entry portal into the MVB pathway.
To examine the inhibitory effect of overexpressed γ2-adaptin
in more detail, we analyzed the solubility proﬁle of cell-associated
EIAV and HIV Gags. Previously, we observed that excess γ2-adaptin
sequestered HBV and MLV structural proteins to detergent-resistant,
aberrant assemblies, a characteristic feature imposed by ectopic
expression of classic dominant negative (dn) inhibitors of the MVB
pathway [10,12,28,29]. Therefore, (co)transfected cells were lysed in
more stringent buffer using the denaturing detergent SDS. Under
these conditions, EIAV Gag could be recovered in almost equal quan-
tities, both in the absence or presence of overexpressed γ2-adaptin
(Fig. 1B). In contrast and to our surprise, the level of HIV.Gag remained
decreased in γ2-adaptin-overexpressing cells (Fig. 1B). To account
for the differences in detergent-speciﬁc solubility, we assumed that
HIV.Gag, but not EIAV.Gag, might be sorted to a destructive pathway
by excess γ2-adaptin. The most likely degradation site might be
lysosomes that receive cargo from MVB/late endosomes. This raised
Fig. 1. Overexpressed γ2-adaptin sequesters EIAV and HIV Gags to detergent-resistant structures and suppresses VLP release. (A) MVB-dependent retroviral Gag budding in HuH-7
cells. Cells were treated with siRNA duplexes targeting Alix (siALIX), Tsg101 (siTsg), or control siRNA (siCon). Two days after transfection, cells were transfected with plasmids
containing EGFP-tagged EIAV.Gag or HIV.Gag. One day later, cells were lysedwith Triton X-100, and VLPs released into themedia were recovered by ultracentrifugation. Lysates were
subjected to Alix- and Tsg101-speciﬁc Western blotting to demonstrate efﬁcient depletion (top). To detect EIAV and HIV Gags, lysates and supernatants were analyzed by anti-GFP
immunoblotting (middle and bottom). (B) EIAV.Gag and HIV.Gag were transfected into HuH-7 cells, either alone or with HA-tagged γ2-adaptin. Cotransfections were done,
respectively, at a 1:3 DNA ratio. Three days posttransfection, cells were lysed using either Triton X-100 or SDS buffer as indicated. Ectopic γ2-adaptin expression was analyzed by HA-
speciﬁc Western blotting (top). Cell-associated Gags and VLPs released into the media were probed with anti-GFP immunoblotting (middle top and middle bottom). The analyses of
the correspondingly SDS lysates are illustrated in the bottom panels. The experiments were repeated three times, and VLPs harvested from the supernatants were quantitated and
demonstrated in percent amount relative to control cells.
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assembly sites in HuH-7 cells so that HIV.Gag can be shunted to
degradation by excess γ2-adaptin, while EIAV.Gag cannot.
3.2. Distinct localization of HIV.Gag and EIAV.Gag in HuH-7 cells
To characterize the assembly sites of HIV and EIAV Gags in HuH-7
cells, we performed deconvolution ﬂuorescence microscopy. The
EGFP-tagged constructs of HIV.Gag and EIAV.Gag were cotransfected
with RFP-tagged Lamp1, a marker of late endosomes/lysosomes. On
sequential optical sections, HIV.Gag was consistently observed in
close association with the Lamp1-positive compartments (Fig. 2A).
In contrast, EIAV.Gag did not colocalize with Lamp1 but rather was
found dispersed throughout the cytoplasm in puncta with a sig-
niﬁcant enrichment at the circumference of the cells (Fig. 2A). One
likely interpretation of this ﬁnding is that in the HuH-7 cell line HIV.
Gag assembly involves endosomal membranes, whereas EIAV.Gag
buds at the plasmamembrane. To conﬁrm this result, TIRFmicroscopy
was performed. Cells were cotransfected with EGFP-tagged EIAV.Gag
and CFP-tagged zyxin, a focal adhesion-associated phosphoprotein
that concentrates at cell–cell junction adhesive complexes [27]. Epi-
ﬂuorescence and TIRF images were taken from the same cell and a
representative example is shown in Fig. 2B. Fluorescence microscopy
revealed general colocalization between EIAV.Gag and zyxin at the
cell periphery and, importantly, the corresponding TIRF image showsa colocalization of both proteins at or beneath the plasma mem-
brane. This is consistent with a report demonstrating EIAV.Gag
budding structures at the cell surface [10]. In the case of HIV-1, the
identity of the cellular membrane used for budding is controversial.
In T-lymphocytes, Gag predominantly completes assembly at the
plasmamembrane, while in macrophages it buds into late endosomes
[30–33]. With regard to our imaging data and biochemical results,
shown below, HIV.Gag clearly engages endosomal structures upon its
assembly in liver cells, even though its ultimate budding site remains
to be identiﬁed.
3.3. Lysosomal inhibition abrogates the γ2-adaptin-induced
down-regulation of HIV.Gag
To determine if the γ2-adaptin-induced down-regulation of HIV.
Gag indeed reﬂects an increase in lysosomal proteolysis, we interfered
selectively with the intralysosomal catabolism. HuH-7 cells were
cotransfected with γ2-adaptin and HIV.Gag and treated with
chloroquine and NH4Cl, drugs that disrupt lysosomal function. As
a control, γ2-adaptin/EIAV-cotransfected cells were examined in
the same manner. Upon drug administration, excess γ2-adaptin no
longer reduced the amount of HIV.Gag recovered from SDS lysates, as
demonstrated by a signiﬁcant higher band intensity of drug-treated
cells in comparison to mock-treated cells (Fig. 3). Hence, inhibiting
lysosomal degradation abrogated the γ2-adaptin-induced down-
Fig. 2. HIV.Gag and EIAV.Gag differ in their intracellular distribution in HuH-7 cells. (A) HuH-7 cells were cotransfected with Lamp1-RFP and EGFP-tagged EIAV.Gag or HIV.Gag at a
1:1 DNA ratio. Cells were ﬁxed, stained with Hoechst 33342, and visualized by deconvolution ﬂuorescence microscopy. Merged images are shown in the right-hand panels. Bar;
10 μm. (B) Cells transiently expressing EIAV.Gag and CFP-tagged zyxin were examined by deconvolution ﬂuorescence microscopy (FM; top) and TIRFM (bottom). The CFP signal of
zyxin is pseudo-colored in red, the EIAV.Gag ﬂuorescence is shown in green. Bar; 10 μm.
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and location of EIAV.Gag, the lysosomotropic agents had no impact on
its intracellular level (Fig. 3).
3.4. Depletion of γ2-adaptin increases HIV.Gag release
Collectively, these data suggest that excess γ2-adaptin interferes
with MVB pathway functions and may promote the conversion of late
endosomal MVBs to lysosomes. To corroborate this idea, we next
analyzed retroviral Gag budding in γ2-adaptin-deﬁcient cells. For
depletion of γ2-adaptin, we previously tested four different siRNAs
[16]. The siRNA duplex #690 was identiﬁed as the most effective
siRNA and applied for silencing analyses. HuH-7 cells were transfected
twice with the siRNA prior to transfection with the EIAV.Gag and HIV.
Gag constructs. Western blot analysis of cell lysates showed that γ2-
adaptin was down-regulated by 70% in siRNAγ2-transfected cells as
compared to control siRNA-treated cells (Fig. 4A and B). When Triton
X-100 lysates were probed for EIAV.Gag, γ2-adaptin depletion had no
effect on the expression and solubility proﬁle of EIAV.Gag. Concor-dantly, EIAV VLP release was virtually unaffected by the depletion of
γ2-adaptin (Fig. 4A). In the case of HIV.Gag, the knockdown of γ2-
adaptin resulted in higher intra- and extracellular Gag levels as
compared to control-treated cells (Fig. 4B). These data indicate that
γ2-adaptin is per se not required for HIV and EIAV VLP production.
Rather, its lack increased the release of such retroviral Gag that
engaged endosomes during budding. One interpretationmight be that
the maturation of endosomal MVBs to lysosomes is impaired in γ2-
adaptin-depleted cells, resulting in a block to lysosomal degradation
of HIV.Gag.
3.5. Mapping of determinants required for the anti-viral budding activity
of overexpressed γ2-adaptin
To specify the γ2-adaptin domain(s) responsible for the seques-
tration of the viral Gags to detergent-resistant fractions and thus for
their export block, we performed transfection studies using different
γ2-adaptin deletion mutants [16,20]. γ2-Adaptin shares the typical
domain structure of large adaptins and consists of an N-terminal head
Fig. 3. Inhibition of lysosomal function suppresses the γ2-adaptin-induced down-
regulation of HIV.Gag. EGFP-tagged EIAV.Gag or HIV.Gag were cotransfected with HA-
tagged γ2-adaptin at a 1:3 DNA ratio, respectively. Two days later, cells were ﬁrst
incubated with cycloheximide to inhibit protein synthesis. Cells were then mock-
treated or treated with chloroquine plus NH4Cl for 4 h and subsequently harvested
in SDS boiling buffer. Lysates were analyzed by GFP-, HA-, and β-actin-speciﬁc
immunoblotting.
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662–785) that are connected by a hinge region (aa 576–661) [21–23].
Full-length γ2-adaptin or mutants that lack the head domain (γ2Δ2–Fig. 4. Depletion of γ2-adaptin increases the release of HIV.Gag, but not of EIAV.Gag. HuH-7 c
siRNA duplexes (siCon). Two days later, cells were transfected with the EIAV.Gag (A) and HIV
were collected from the cell supernatants. To monitor depletion of γ2-adaptin, lysates were p
of sample loading was conﬁrmed by probing the extracts with anti-tubulin antibodies (m
immunoblotting (middle bottom and bottom). The experiments were repeated three time
percent amount relative to control cells.522), the hinge/ear domain (γ2Δ528–785), or large parts of the
protein (γ2Δ193–785) including the ubiquitin-interacting motif
(UIM) were cotransfected with EIAV.Gag or HIV.Gag. As shown in
Fig. 5A, the wt and mutant γ2-adaptin proteins were expressed at
same levels and could be identiﬁed by their predicted molecular
weights. By inspecting the amounts of Triton X-100-soluble Gags in
lysates and VLPs in supernatants, excess wt γ2-adaptin reduced EIAV
and HIV Gag solubility and budding as above (Fig. 5A and B). Similar
inhibitory activities were observed for the γ2Δ528–785 mutant and
even for the severely truncated γ2Δ193–785 form. In contrast, the N-
terminal γ2Δ2–522 mutant consistently did not impair EIAV and HIV
VLP production (Fig. 5A and B). These data indicate that the hinge
and ear domain are dispensable for the inhibitory action of excess
γ2-adaptin. Rather, the ﬁrst 192 aa of γ2-adaptin are primarily
essential for the suppression of HIV and EIAV VLP production. From
these data we also deduce that the UIM of γ2-adaptin and its UIM-
directed interaction with Nedd4 are not directly involved in its
down-regulating activity.
3.6. Anti-viral budding activity of overexpressed γ2-adaptin depends on
the ESCRT machinery
To investigate whether the anti-viral budding activity of up-
regulated γ2-adaptin is linked to ESCRTs, the fate of EIAV.Gag was
studied in the absence of Alix. EIAV.Gag buds from the plasma
membrane where it recruits Alix. Alix in turn interacts with ESCRT-I
and -III subunits thereby recruiting the ESCRT machinery to the EIAV.
Gag budding site [1,2,10]. We therefore asked whether γ2-adaptin is
able to down-regulate EIAV.Gag in Alix-depleted cells. Cells wereells were transfected twice with siRNA duplexes targeting γ2-adaptin (siγ2) or control
.Gag (B) constructs. After an additional day, cells were lysedwith Triton X-100, and VLPs
rocessed forWestern blotting using an antiserum against γ2-adaptin (top). Uniformity
iddle top). Intracellular and extracellular Gag levels were analyzed by GFP-speciﬁc
s, and VLPs harvested from the supernatants were quantitated and demonstrated in
Fig. 5. Mapping of γ2-adaptin domains responsible for its anti-viral budding activity. (A) HuH-7 cells were cotransfected with EIAV.Gag plus vectors bearing the wt or indicated
mutant γ2-adaptin proteins in HA-tagged form. Synthesis of γ2-adaptin and its mutants is shown by HA-speciﬁc immunoblotting of Triton X-100 lysates (top). Cells were assayed
for overall protein expression and viability by anti-β-actin Western blotting (middle top). EIAV.Gag expression and solubility (middle bottom) and VLP release efﬁciency (bottom)
were determined by GFP-speciﬁc immunoblotting. (B) The cotransfection experiment was done with the HIV.Gag construct, exactly as outlined in (A). (C) The anti-viral activity of
γ2-adaptin depends on the ESCRT-recruiting factor Alix. Cells were treated with control and Alix siRNAs and retransfected with EIAV.Gag (1 μg) together with increasing amounts of
γ2-adaptin (0, 1, 2, or 3 μg). Triton X-100 lysates were analyzed by Alix- (top) and GFP-speciﬁc (bottom) immunoblotting.
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together with increasing amounts of the γ2-adaptin construct.
The analysis of Triton X-100 lysates revealed that excess γ2-adaptin
failed to sequester EIAV.Gag to detergent-resistant fractions, if Alix is
lacking (Fig. 5C). This ﬁnding implies that the inhibitory activity of
excess γ2-adaptin requires the ESCRT-recruiting capability of Alix.
3.7. Effect of γ2-adaptin overexpression/silencing on the
endosome–lysosome degradation pathway
To further dissect the role for γ2-adaptin in the MVB/lysosomal
pathway, we focused on physiological substrates andmajor regulators
of this process. Natural substrates destined for MVB/lysosomes are
usually modiﬁed with ubiquitin that acts as a sorting signal for their
lysosomal delivery and degradation. Therefore, an inactivation of MVB
pathway functions results in accumulation of ubiquitinated proteins
on endosomal structures [1,2]. If γ2-adaptin is indeed an intimate
player of this pathway, both overexpression and depletion should
affect the pool of ubiquitinated conjugates. To reduce or increase
γ2-adaptin synthesis, HuH-7 cells were transfected with siRNAs or
its HA-tagged construct, respectively, and subsequently analyzed by
deconvolution immunoﬂuorescence microscopy. Depletion efﬁcacy
of γ2-adaptin was visualized by staining with antibodies against γ2-
adaptin, whereas the HA-speciﬁc antibody was used to detect
overexpressing cells. In both settings, cells were costained with an
antibody (FK2) that speciﬁcally recognizes conjugated ubiquitin.
To conﬁrm the speciﬁcity of this antibody, cells were mock-treated
or treated with MG-132, a drug that inhibits proteasomal degrada-
tion of ubiquitinated proteins. As shown in Fig. 6A, the pool of
ubiquitinated proteins recognized by FK2 clearly increased in thepresence of MG-132. Upon depletion of γ2-adaptin, a striking
accumulation of ubiquitin conjugates was observed (Fig. 6A).
Contrary, in γ2-adaptin-overexpressing cells the pool of ubiquiti-
nated proteins was substantially decreased (Fig. 6A). Given that the
depletion of γ2-adaptin restricts, while its overexpression accel-
erates the turnover of ubiquitinated conjugates, these observations
add further hints that γ2-adaptin is involved in MVB/lysosomal
trafﬁcking.
As a second biological readout, we monitored endocytosis of EGF
that, subsequent to binding to its receptor at the cell surface, is
internalized and delivered, via the MVB pathway, to the lysosomal
lumen for degradation [34]. Our previous studies had implicated an
involvement of γ2-adaptin in EGF turnover, as its depletion impairs
EGF degradation and results in EGF accumulation to enlarged
endosomal structures [20]. Here, we investigated the fate of EGF in
γ2-overexpressing cells. Cells transfected with HA-tagged γ2-adaptin
were pulse-incubated with Alexa-conjugated EGF for 20 min and
analyzed either directly or after a chase of 120 min. During the pulse,
no difference in EGF loading and uptake was observed between γ2-
adaptin-overexpressing and control cells (Fig. 6B). However, in cells
pulse-chased for the relatively short period of 120 min, a substantial
amount of EGF could still be detected in control cells, whereas an
almost complete disappearance of internalized EGF in γ2-over-
expressing cells was found at this time (Fig. 6B). This indicates that
up-regulated γ2-adaptin accelerates the lysosomal degradation of
EGF, as it is also shown for HIV.Gag and ubiquitin conjugates.
Because γ2-adaptin is classiﬁed as a clathrin adaptor-related
protein [22], the manipulation of γ2-adaptin levels might interfere
with clathrin-dependent trafﬁcking processes. To address this point,
we analyzed the internalization of transferrin, a bona ﬁde cargo of
Fig. 6. Alterations of γ2-adaptin levels interfere with the endosome–lysosome degradation pathway. (A) Depletion and overexpression of γ2-adaptin affect the intracellular level of
ubiquitinated proteins. The speciﬁcity of the mouse anti-ubiquitin FK2 antibody for ubiquitinated proteins (Ub) is shown by immunostaining of HuH-7 cells that were mock-treated
or treated with MG-132. The distribution pattern of ubiquitinated conjugates was analyzed in cells treated with anti-γ2-adaptin siRNA and in cells transfected with HA-tagged γ2-
adaptin. Cells were stained with the FK2 antibody (Ub; green), together with either a rabbit antiserum against endogenous γ2-adaptin (red) or a rat anti-HA antibody recognizing
exogenous γ2-adaptin (red). DNA staining of the cell nuclei is shown in blue color. Bar; 10 μm. Digital photographs were quantitated using ImageJ software by measuring the
integrated ﬂuorescence density of selected cells (40 cells per coverslip; n=3). Quantitated ﬂuorescence intensities (relative ﬂuorescent units) are expressed in percent amount
relative to correspondingly transfected control cells (right graphs; Con, control-transfected cells; γ2−, γ2-depleted cells; γ2+, γ2-overexpressing cells). (B) Overexpression of γ2-
adaptin accelerates EGF degradation. The fate of internalized Alexa 488-EGF was analyzed in HuH-7 cells transfected with HA-tagged γ2-adaptin. Cells were stimulated with EGF for
20 min and examined for Alexa 488-EGF (green), the HA-tag of γ2-adaptin (red), and DNA staining, either directly (top) or after a chase of 120 min (bottom). Bar; 10 μm.
Fluorescence density was recorded using ImageJ, exactly as in (A).
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Fig. S1, neither the depletion nor the overexpression of γ2-adaptin
affected the uptake of labeled transferrin. In contrast, transferrin
internalization was greatly impaired in cells depleted for clathrin
heavy chain (Fig. S1). In addition, we focused on clathrin per se as well
as on γ1-adaptin, a classic clathrin adaptor protein, and examinedtheir intracellular distribution pattern in cells with reduced or
increased γ2-adaptin synthesis. Immunoﬂuorescence microscopy
did not reveal signiﬁcant differences in the distribution of clathrin
and γ1-adaptin between control and γ2-adaptin-manipulated cells
(Fig. S1). We conclude that the alteration of γ2-adaptin levels does
not impair clathrin-mediated trafﬁcking.
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machinery
Besides its effects on cargoes, we inspected the impact of γ2-
adaptin on the MVBmachinery per se. Because ESCRT complexes form
the main machinery driving protein sorting from endosomes to
lysosomes, key subunits of these complexes were studied under
conditions of altered γ2-adaptin expression. First, we focused on the
ESCRT-III subunit CHMP3, involved in membrane deformation and
vesicle abscission, and the Vps4 ATPase, responsible for disassembly
and recycling of the ESCRT complex [1,5,36]. We took advantage that
Chmp3 and Vps4 can be ectopically expressed in either wt or dn
versions so that the phenotype of both forms can be directly
compared. CHMP proteins can be converted to potent dn forms by
fusion to a large heterologous protein, like YFP, whereas the activity of
Vps4 can be suppressed by overexpression of its corresponding
mutant with defects in ATP hydrolysis [9,17,29]. Both dn CHMP3 and
dn Vps4 had been shown to impair the MVB pathway, resulting in
enlarged aberrant endosomes on whose surfaces they are entrapped
themselves [10,28,29]. The YFP/GFP-tagged wt and dn forms of
CHMP3 and Vps4A were expressed in HuH-7 cells with or without
HA-tagged γ2-adaptin followed by lysis with Triton X-100 or SDS. If
expressed alone, wt/dn Chmp3 and Vps4A were readily detectable by
GFP-speciﬁc immunoblotting of Triton X-100 extracts (Fig. 7). In the
presence of excess γ2-adaptin, however, the amounts of both proteins
were severely diminished, irrespective of their wt or dn phenotype
(Fig. 7). The analysis of the SDS lysates of (co)transfected cells
revealed that the wt forms of CHMP3 and Vps4A could be recovered,
while their according dn mutants could not (Fig. 7). Almost identical
results were obtained with representative components of the ESCRT-I
and -II complexes, including Tsg101, Vps28, and EAP30 (data not
shown). Hence, overexpressed γ2-adaptin not only entraps retroviral
Gags but even intrinsic players of the MVB network to detergent-
resistant structures. Lysosomal inhibition and γ2-adaptin knockdown
studies performed with dn CHMP3 and dn Vps4A perfectly paralleled
the results obtained with HIV.Gag, as anti-lysosomal drug treatmentFig. 7. Overexpression of γ2-adaptin down-regulates ESCRT-III subunits and Vps4A. HuH-
(A, middle left), GFP-tagged Vps4A.wt (B, middle right), or Vps4A.dn (B, right) with or witho
adaptin are shown in the left-hand lanes of each panel. Cells were lysed with Triton X-100 o
speciﬁc antibodies.abrogated the γ2-adaptin-induced down-regulation, while γ2-adap-
tin silencing increased the steady-state levels of dn CHMP3 and dn
Vps4A (Supplemental Fig. S2). Collectively, these observations
identify γ2-adaptin as a critical factor contributing to proper MVB
homeostasis and trafﬁcking.
3.9. γ2-Adaptin interacts with Vps28 and CHMP2A
These ﬁndings raised the question how γ2-adaptin may access the
MVB machinery. To address this issue, we analyzed whether γ2-
adaptin might interact with ESCRT components. HA-tagged γ2-
adaptin was cotransfected with FLAG-tagged Vps28, EAP30,
CHMP2A, CHMP3, CHMP4B, or CHMP4C at a 1:1 DNA ratio. Cell
extracts were probed with epitope-speciﬁc antibodies to conﬁrm
efﬁcient synthesis of γ2-adaptin and the ESCRT constructs (Fig. 8A).
Lysates were next subjected to immunoprecipitation with anti-FLAG-
speciﬁc antibodies, and the immune complexes were examined by
HA-speciﬁc immunoblotting. As shown in Fig. 8A, γ2-adaptin was
indeed coprecipitated with Vps28 and to a lesser extent with
CHMP2A. These interactions were speciﬁc, as EAP30, CHMP3,
CHMP4B, and CHMP4C reproducibly failed to coprecipitate with γ2-
adaptin (Fig. 8A). Moreover, by performing similar coimmunopreci-
pitation assays, we could not detect any interaction between γ2-
adaptin and other ESCRT components, including EAP45, CHMP1B,
CHMP5, CHMP6, and Vps4 (data not shown). Hence, these ﬁndings
demonstrate that γ2-adaptin physically interacts with the ESCRT-I
subunit Vps28 and the ESCRT-III member CHMP2A.
To corroborate these results, we performed deconvolution immu-
noﬂuorescence microscopy to visualize the distribution of γ2-adaptin
and Vps28 or CHMP2A in cotransfected cells. As above, γ2-adaptin
yielded a cytoplasmic vesicular staining with some enrichment in
punctuate structures (Fig. 8B). Vps28 was found mostly dispersed
throughout the cytoplasm and, importantly, an overlay of the ﬂuo-
rescence patterns revealed an extensive degree of colocalization of
Vps28 and γ2-adaptin (Fig. 8B). A weaker, but nonetheless substantial
colocalization in cytoplasmic vesicular structures was also observed7 cells were transfected with FLAG-tagged CHMP3.wt (A, left), YFP-tagged CHMP3.dn
ut HA-tagged γ2-adaptin at a 1:3 DNA ratio, respectively. Single transfections with γ2-
r SDS containing buffers as indicated, and extracts were probed with tag- and β-actin-
Fig. 8. γ2-Adaptin interacts with the ESCRT subunits Vps28 and CHMP2A. (A) HuH-7 cells were cotransfectedwith HA-tagged γ2-adaptin together with FLAG-tagged ESCRT subunits
as denoted above each lane. Each cotransfection was done at a 1:1 DNA ratio, and empty plasmid was used as a negative control (control). Stable synthesis (input) of γ2-adaptin and
the ESCRT constructs is shown by simultaneous immunoblotting of lysates with anti-HA and anti-FLAG antibodies (top). The input amounts correspond to 10% of the samples used
for immune capture. For coimmunoprecipitation (IP), lysates were incubated with anti-FLAG antibodies before Western blotting (WB) with the HA-speciﬁc antibody (bottom).
(B) γ2-Adaptin colocalizes with Vps28 and CHMP2A. Cells were cotransfected with HA-tagged γ2-adaptin and FLAG-tagged Vps28 (top), CHMP2A (middle) or CHMP3 (bottom) and
immunostained with mouse anti-FLAG and rat anti-HA antibodies. After staining with secondary antibodies, cells were analyzed by deconvolution ﬂuorescence microscopy. The
staining pattern of the ESCRT constructs is shown in green and the ﬂuorescent signal of γ2-adaptin is in red. The overlays of the ﬂuorescence patterns are shown in the right column
with yellow color indicating colocalization. DNA staining is shown in blue. Bar; 10 μm. (C) The N-terminal head domain of γ2-Adaptin binds to Vps28. HA-tagged γ2Δ193–785 and
γ2Δ2–552 were cotransfected with FLAG-tagged Vps28 or CHMP2, and cell extracts were analyzed by the coimmunoprecipitation assay. Extracts were tested for the input amounts
of the constructs by speciﬁc Western blotting (top and middle), and the immune capture is shown in the bottom panels.
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could be detected for CHMP3 and γ2-adaptin (Fig. 8B).
Finally, we examined the binding capacity of the γ2Δ193–785 and
γ2Δ2–522 mutants that are, respectively, able or unable to suppressVLP production. The mutants were cotransfected with either Vps28 or
CHMP2B and analyzed by the coimmunoprecipitation assay as above.
Both mutants still interact with CHMP2A with comparable intensities
(Fig. 8C). In contrast, the γ2Δ2–522 mutant that has lost the anti-viral
1262 T. Döring et al. / Biochimica et Biophysica Acta 1803 (2010) 1252–1264activity failed to coprecipitate with Vps28, while γ2Δ193–785 did
(Fig. 8C). These data imply that the association of γ2-adaptin with
Vps28 is primarily responsible for its inhibitory action on ESCRT-
dependent virus budding.
4. Discussion
This study demonstrates the importance of γ2-adaptin in the
ESCRT-mediated MVB/lysosome sorting pathway. Functional studies
based on its overexpression and silencing provide evidence that γ2-
adaptin is speciﬁcally required for degradative endocytic trafﬁcking
and may help in maintaining homeostasis of the MVB apparatus.
By using retroviral budding as a model to study the function of γ2-
adaptin, we found that its excess potently inhibits the MVB-
dependent egress of HIV-1 and EIAV VLPs in transfected liver cell
lines. These results are in linewith our previouswork demonstrating a
block to MLV Gag budding by exogenous γ2-adaptin [12]. All these
viruses require the activities of the late-acting ESCRT-III and Vps4, but
differ in their entry gates to the MVB machinery that is dictated by
their distinct late domains [7–10]. Since overexpressed γ2-adaptin
perturbs retroviral Gag release irrespective of the L domain type,
it appears to act downstream within the canonical ESCRT cascade.
Virus release inhibition coincided with the sequestration of viral Gags
to detergent-resistant structures, a characteristic property of classic
MVB inhibitors, like dn versions of the ESCRT-III forming CHMPs and
catalytically inactive Vps4 mutants [10,28,29]. Hence, overexpressed
γ2-adaptin shares features with these inhibitors, as it globally
disrupts MVB-dependent virus budding.
To our surprise, the analysis of the sequestered phenotypes
revealed that exogenous γ2-adaptin led to a down-regulation of
HIV.Gag, but not of EIAV.Gag. This apparent paradox likely originated
from different budding sites, as EIAV.Gag is localized at the plasma
membrane, while HIV.Gag accumulates in endosomal/lysosomal
structures in HuH-7 cells. Accordingly, overexpressed γ2-adaptin
accelerates the lysosomal degradation of a “viral cargo”, if sequestered
to endosomal compartments. Consistent with this, depletion of γ2-
adaptin enhances HIV, but not EIAV particle release, likely by rescuing
HIV.Gag from lysosomal clearance. These ﬁndings are consistent
with a recent study which demonstrated that inhibiting lysosomal
degradation induced an accumulation of HIV-1 Gag in endosomes and
impressively increased virus production in human ﬁbrosarcoma cells
[33].
Our silencing analysis indicates that γ2-adaptin is per se not
essential for retroviral VLP production. A similar phenotype had been
reported for CHMP5, an ESCRT-III accessory subunit [37]. Analysis of
homozygous knockout of CHMP5 in mice revealed a defect in fusion
between MVBs and lysosomes, concomitant with defective lysosomal
cargo degradation [38]. In human cells, CHMP5 depletion leads to an
increase in HIV particle release, implicating that its presence in the cell
actually inhibits retroviral egress [37]. Possibly, the lack of CHMP5
facilitates export of HIV by avoiding its arrival in lysosomes for ﬁnal
destruction. Thus, CHMP5 and γ2-adaptin may perform related
functions within the late endosomal MVB/lysosome pathway, e.g.
recruiting fusion-mediating components. One such component might
be the late endosome-associated Rab7 GTPase that mediates matu-
ration of late endosomes and phagosomes, and their fusion with
lysosomes [39]. In favor of this assumption, we observed a func-
tional relationship between γ2-adaptin and Rab7 (K. Gotthardt and
R. Prange, unpublished observation).
Besides viral infection models, we focused on endogenous MVB
cargoes to determine whether γ2-adaptin physiologically functions
within the endosomal–lysosomal trafﬁc. The analysis of well-
established cargoes, like ubiquitinated conjugates and EGF, led to a
similar outcome. If down-regulated, γ2-adaptin induces an accumu-
lation of ubiquitinated cargoes, while its up-regulation diminishes
that pool. Likewise, the depletion of γ2-adaptin impairs [20] and itsexcess accelerates lysosomal degradation of EGF, what, further-
more, argues for a role of γ2-adaptin in MVB/lysosome maturation.
In support of its MVB-associated function, overexpressed γ2-adaptin
even affects the ESCRT machinery, as evidenced by the entrapment of
ESCRT complex members and Vps4 to detergent-insoluble polymers.
This sequestration, however, had different consequences, as wt ESCRT
subunits could be recovered from the tethered assemblies, whereas
their dn versions could not. Apparently, the dn mutants, irreversibly
trapped to endosomal structures due to their own defects, were
shunted to lysosomal degradation by virtue of excess γ2-adaptin.
Collectively, these data indicate that alteration of γ2-adaptin levels
results in a global disruption in protein sorting to or the formation
of lysosomes from late endosomes, rather than to a speciﬁc deﬁcit in
the sorting of select proteins into lysosomes. Because dn mutants of
the ESCRT-III subunit CHMP3 and Vps4 are blocked in ILV formation
and hence should not end up in those vesicles [1,9,36], but were
nonetheless targeted to enhanced lysosomal destruction by excess
γ2-adaptin, the adaptor appears to function independently of ILV
abscission. Future electron microscopy studies should help to unravel
this issue.
A possible role of γ2-adaptin in MVB/lysosome transition was
recently also suggested by Rüder et al. who identiﬁed an interaction
between γ2-adaptin and the estrogen receptor-binding fragment-
associated antigen 9 (EBAG9), a tumor-associated antigen [40]. EBAG9
controls the release of secretory lysosomes from cytotoxic T-cells and,
if overexpressed, represses their release [41]. Loss of EBAG9 enhances
the sorting of granzyme B to secretory lysosomes, resulting in an
increased cytolytic activity [40]. Thus, EBAG9 could act as a negative
modulator of the endosomal–lysosomal trafﬁcking route by inhibiting
γ2-adaptin function [40,42]. The absence of EBAG9 would in turn give
rise to enhanced activity of γ2-adaptin in terms of MVB-to-lysosome
maturation, a condition equivalent to up-regulated γ2-adaptin.
The interference of excess γ2-adaptin with both, MVB cargo
sorting and the MVB apparatus, pointed to an intimate interplay
between the adaptor and the ESCRT network. Previously, we iden-
tiﬁed a functional interaction between γ2-adaptin and Nedd4 which
depends on the γ2-adaptin-speciﬁc UIM and promotes its ubiquitina-
tion [20]. Although Nedd4 is not an intrinsic player of the MVB
pathway, it is proposed to escort cargoes to the ESCRT machinery
[7,8,15]. This led us to suggest that γ2-adaptin might gain access to
this machinery by means of its Nedd4 binding ability [20]. However,
our mapping analysis revealed that the UIM and the UIM-directed
Nedd4 interaction are dispensable for the anti-viral budding activity
of excess γ2-adaptin. Rather, γ2-adaptin might enter the ESCRT
pathway via its interactions with Vps28 and CHMP2A.
Although the functional relevance of these interactions remains to
be disclosed, the association of γ2-adaptin with Vps28 appears be of
particular importance. By mapping regions of γ2-adaptin involved in
binding to Vps28 and required for its anti-viral action, we found that
its N-terminal 192 amino acids are sufﬁcient and essential. Intrigu-
ingly, the loss of the Vps28 binding ability coincides with the inability
of excess γ2Δ2–522 to suppress virus egress, pointing toward a
productive interaction between γ2-adaptin and Vps28. Although this
association is seemingly not essential for MVB-dependent viral
budding, the dn effect exhibited by overexpressed γ2-adaptin might
be due to a competition or interference with Vps28 and hence the
ESCRT complex, reminiscent of a substrate trap effect. Substrates
irreversibly trapped on late endosomes/MVBs by γ2-adaptin would
ﬁnally end up in lysosomes for proteolysis.
The association between γ2-adaptin in CHMP2 is apparently
bipartite and involves N- and C-terminal regions of the adaptor.
CHMP subunits had been shown to cycle between two states: soluble
monomers and higher-order assemblies that bind and remodel
membranes during ILV formation [36,43–45]. Based on their highly
polarized charge distribution, soluble CHMPs are autoinhibited via
intramolecular interaction between the basic N-terminus and acidic
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released by overexpression of AMSH, its natural binding partner, and
results in the conversion of CHMP3 into a potent inhibitor of HIV-1
egress [43]. Similarly, the interaction of γ2-adaptin with CHMP2A
might unmask new properties of this ESCRT-III member, like in-
appropriate opening of its closed inactive conformation. As CHMP2 is
required for the recruitment of Vps4 to endosomes [46,47], it seems
also possible that binding to excess γ2-adaptin might shield the
CHMP2 recognition site for Vps4, thereby interfering with MVB/
lysosome trafﬁcking.
We do not yet know the precise mechanistic action of γ2-adaptin,
but its linkage to Vps28 and CHMP2 led us to speculate that it may
coordinate proper ESCRT assembly. For its correct function in MVB
trafﬁc, the concentration of γ2-adaptinmust be seemingly keptwithin
critical concentration thresholds. A regulatory role in the coordination
of MVB trafﬁc had been also described for the Rab7-interacting
lysosomal protein RILP that interacts with ESCRT-II and controls late
endosome function [48,49]. Both,γ2-adaptin andRILP are only present
in metazoans such as mammals but not in yeast, suggesting that
the γ2-adaptin/ESCRT and RILP/ESCRT loops of regulation could be
unique to higher multicellular eukaryotes. By orchestrating the
ESCRT cascade, γ2-adaptinmay simultaneously function as an adaptor
recruiting components that are needed for MVBs function and their
transition to lysosomes. Good candidates for such components might
be the Rab7 GTPase, Rab7 effectors and/or the homotypic fusion and
vacuole protein (HOPS) complex that are required forMVB/lysosomes
fusion [3]. Alternatively, due to its strong membrane binding property
[20], γ2-adaptin – physically linked to ESCRT subunits –may mediate
direct contacts between the MVB and lysosomal membranes and
hence may tether membranes. Understanding how γ2-adaptin
mechanistically operates within MVB/lysosomal network – either as
a monomer or part of a hitherto unknown adaptor protein complex –
will be an important next step forward.
Supplementarymaterials related to this article can be found online
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